Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
The combined company will feature a synergistic platform which is expected to enable the development of best-in-class targeted cancer therapies across multiple modalities.
Lead Product(s): Undisclosed
Therapeutic Area: Oncology Product Name: Undisclosed
Highest Development Status: Discovery PlatformProduct Type: Undisclosed
Partner/Sponsor/Collaborator: Immunome
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Merger October 03, 2023
Details:
The combined company will feature a synergistic platform which is expected to enable the development of best-in-class targeted cancer therapies across multiple modalities.
Lead Product(s): Undisclosed
Therapeutic Area: Oncology Product Name: Undisclosed
Highest Development Status: PreclinicalProduct Type: Small molecule
Partner/Sponsor/Collaborator: Immunome
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Merger June 29, 2023